Society for Immunotherapy of Cancer (SITC) - Dedicated to improving cancer patient outcomes by advancing the field of tumor immunology and cancer immunotherapy.
#CIM – On Forward Fund Friday, we recognize the opportunities provided through your donations. Providing Early Career Scientists, the funding to share their research through travel awards is catapulting careers in #IO. Contribute and make an impact today. givebutter.com/sitc-forward-…
Join us for the Targets for Cancer IO: A Deep Dive Series—an expert-led webinar program exploring cutting-edge science and therapeutic innovation in immuno-oncology. Learn more about these webinars and register here: sitcancer.org/edu/webinars/t…
New #JITC article: "Inhibition of histone demethylase LSD1 suppresses CD47 expression and enhances efficacy of CD47 blockade in breast cancer" jitc.bmj.com/content/14/6/e0…
Cancer vaccines continue to evolve. Hear from Lisa H. Butterfield, PhD, on the latest advances, opportunities and challenges in vaccine development and their role in the future of immunotherapy. Sept. 3–4 in Lausanne, Switzerland. sitcancer.org/edu/edu-sitc-b…
#CIM – It’s Forward Fund (FF) Friday. Your donation to the FF provides ECS opportunities to share their research w/ IO leaders through SITC travel awards & Early Career Investigator Awards. Your support is launching careers in IO to benefit Cx patients. givebutter.com/sitc-forward-…
New #JITC commentary: "Targeting B7-H3 in patients with metastatic triple-negative breast cancer and brain metastases: an opportunity to “revive” immunotherapy as a treatment strategy?" jitc.bmj.com/content/14/6/e0…@JerzakKasia@UofT_DoM
Only two weeks left to submit your Abstracts for #SITC26! All accepted Abstracts will have the opportunity to present a poster in the Poster Hall and are published in @jitcancer. Submit your Regular or Early Career Investigator Award Abstracts by June 25. sitcancer.org/2026/abstracts…
2026 #SITC Biotech Strategic Meeting at the @NYSE brings together biotech leaders & investors for insights on IPO market trends from Daina Graybosch, PhD, and IO financing, dealmaking, & partnership trends from Andrew Baum, MD. Register: sitcancer.org/about/strategi…@OncoDailyBio
ONE DAY LEFT to nominate a leader in #IO for SITC’s Steven A. Rosenberg Scholars Award. The recipient will receive $150,000 in research funding and be recognized during an Award Ceremony at #SITC26. LEARN MORE: sitcancer.org/rosenberg#SITCForwardFund
New #JITC short report: "CD19/CD22 bivalent CAR T cells in children, adolescents and young adults with B-ALL: final phase 1 trial results" jitc.bmj.com/content/14/6/e0…